Explanatory Note:
This joint statement on Schedule 13D/A (this “Statement”) is filed with respect to the common stock, par value $0.01 per share (“Common Stock”), of Aptinyx Inc., a Delaware corporation (the “Issuer”).
This Amendment No. 3 (this “Amendment”) amends and supplements the Schedule 13D originally filed with the Commission on July 2, 2018, as amended by Amendment No. 1 filed with the Commission on February 12, 2020 and Amendment No. 2 filed with the Commission on February 14, 2023 (collectively, the “Original Schedule 13D”). This Amendment is being filed to update the aggregate percentage of the Issuer’s Common Stock owned by the Reporting Persons due to sales of the Reporting Persons Common Stock since the date of the filing of the Original Schedule 13D. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act was filed as Exhibit 1 to the Original Schedule 13D. Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13D remain unchanged. Capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Original Schedule 13D. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.
Item 5. | Interest in Securities of the Issuer |
Item 5 is amended and supplemented as follows:
(a) and (b) See Items 7-11 of the cover pages herein and Item 2 of the Original Schedule 13D.
(c) Except as described herein, the Reporting Persons did not effect any transactions in shares of the Issuer’s Common Stock during the sixty day period prior to the filing of this Amendment.
On March 2, 2023, Longitude Venture II sold 292,331 shares of Common Stock at a weighted-average sale price of $0.1813 per share and an aggregate sale price of $52,999.61.
On March 3, 2023, Longitude Venture II sold 251,870 shares of Common Stock at a weighted-average sale price of $0.1751 per share and an aggregate sale price of $44,102.44.
On March 6, 2023, Longitude Venture II sold 1,637,925 shares of Common Stock at a weighted-average sale price of $0.1922 per share and an aggregate sale price of $314,809.19.
On March 7, 2023, Longitude Venture II sold 733,419 shares of Common Stock at a weighted-average sale price of $0.1856 per share and an aggregate sale price of $136,122.57.
On March 8, 2023, Longitude Venture II sold 441,201 shares of Common Stock at a weighted-average sale price of $0.1551 per share and an aggregate sale price of $68,430.28.
On March 8, 2023, Patrick Enright sold 95,000 shares of Common Stock at a weighted-average sale price of $0.1508 per share and an aggregate sale price of $14,326.00.
On March 13, 2023, Juliet Tammenoms Bakker sold 66,666 shares of Common Stock at a weighted-average sale price of $0.1432 per share and an aggregate sale price of $9,546.57.
(e) On March 6, 2023, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the outstanding shares of Common Stock.
Item 7. | Material to be Filed as Exhibits. |
| | |
Exhibit 6: | | Power of Attorney (Patrick Enright) (filed herewith). |
Exhibit 7: | | Power of Attorney (Juliet Tammenoms Bakker) (filed herewith). |